Taenia solium cysticerci's extracellular vesicles Attenuate the AKT/mTORC1 pathway for Alleviating DSS-induced

Suraj Singh Rawat1, Anand Kumar Keshri1, Naina Arora1

  • 1School of Biosciences and Bioengineering, Indian Institute of Technology Mandi, Mandi, Himachal Pradesh, India.

Insights

Taenia solium larvae extracellular vesicles (EVs) suppress macrophage immune responses by degrading AKT and mTOR, promoting apoptosis. These EVs may contribute to immunosuppression during early neurocysticercosis (NCC) and offer therapeutic potential.

Area of Science:

  • Parasitology
  • Immunology
  • Cell Biology

Background:

  • Excretory-secretory products of pathogens like Taenia solium are crucial for disease progression and immune evasion.
  • Neurocysticercosis (NCC), caused by T. solium cysticerci, is a significant public health issue in developing nations.
  • Extracellular vesicles (EVs) are key components of the secretome, but their role in NCC pathogenesis is unknown.

Purpose of the Study:

  • To investigate the role of extracellular vesicles (EVs) from Taenia solium larvae in neurocysticercosis (NCC) pathogenesis.
  • To elucidate the mechanism by which T. solium EVs interact with host immune cells.
  • To explore the potential therapeutic applications of T. solium EVs.

Main Methods:

  • Characterization of metabolites within T. solium larval EVs.
  • In vitro studies involving the internalization of EVs by macrophages.
  • Analysis of key signaling pathways (PI3K/AKT/mTOR), protein degradation, reactive oxygen species (ROS) production, and apoptosis in EV-treated macrophages.
  • In vivo studies using a mouse model of DSS-induced colitis.

Main Results:

  • T. solium EVs contain metabolites that inhibit the PI3K/AKT pathway.
  • EVs are internalized by macrophages, leading to AKT and mTOR degradation via the autolysosomal pathway and increased ubiquitination.
  • EV treatment reduces macrophage ROS production and bacterial killing capacity, upregulating macro-autophagy and apoptosis.
  • T. solium EVs demonstrated a protective effect in a DSS-induced colitis mouse model, improving colon architecture.

Conclusions:

  • T. solium EVs from viable cysts attenuate the AKT-mTOR pathway, inducing apoptosis in macrophages and potentially mediating immunosuppression during early NCC.
  • EV-mediated immunosuppression by T. solium may be a critical factor in the asymptomatic phase of NCC.
  • T. solium EVs possess immunomodulatory properties with potential therapeutic applications for inflammatory conditions like colitis.